Covered recipient · General Payments record
MARK P GOODMAN
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2024
$3,144.33
- Reported across 146 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $678.61 | 31 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $165.79 | 9 |
| Amgen Inc. | $144.33 | 7 |
| Lilly USA, LLC | $83.27 | 3 |
| Novo Nordisk AS | $71.68 | 3 |
| PFIZER INC. | $40.71 | 2 |
| GlaxoSmithKline, LLC. | $32.86 | 1 |
| Edwards Lifesciences Corporation | $31.31 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $26.26 | 1 |
| HEARTFLOW, INC. | $23.56 | 1 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $23.17 | 1 |
| Acerta Pharma LLC | $20.35 | 1 |
| IBSA Pharma Inc. | $15.32 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (31)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $22.27 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103819402 | CMS |
| ABBVIE INC. | $22.23 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103819404 | CMS |
| ABBVIE INC. | $1.20 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103819406 | CMS |
| ABBVIE INC. | $28.49 | 07/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103819408 | CMS |
| ABBVIE INC. | $27.21 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103819410 | CMS |
| ABBVIE INC. | $1.20 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103819412 | CMS |
| ABBVIE INC. | $21.56 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103819414 | CMS |
| ABBVIE INC. | $18.06 | 11/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103819416 | CMS |
| ABBVIE INC. | $23.57 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103819418 | CMS |
| Amgen Inc. | $25.39 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111586982 | CMS |
| Amgen Inc. | $10.51 | 02/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117263843 | CMS |
| Amgen Inc. | $15.13 | 03/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117263845 | CMS |
| Amgen Inc. | $19.34 | 06/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111586984 | CMS |
| Amgen Inc. | $22.12 | 06/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117263847 | CMS |
| Amgen Inc. | $32.05 | 08/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111586986 | CMS |
| Amgen Inc. | $19.79 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117263849 | CMS |
| AstraZeneca Pharmaceuticals LP | $20.35 | 10/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104548486 | CMS |
| Edwards Lifesciences Corporation | $31.31 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138873871 | CMS |
| GlaxoSmithKline, LLC. | $32.86 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116334353 | CMS |
| HEARTFLOW, INC. | $23.56 | 11/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154180730 | CMS |
| IBSA Pharma Inc. | $15.32 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142975725 | CMS |
| Lilly USA, LLC | $31.41 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135163337 | CMS |
| Lilly USA, LLC | $22.68 | 04/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135118401 | CMS |
| Lilly USA, LLC | $29.18 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135168778 | CMS |
| Novartis Pharmaceuticals Corporation | $26.26 | 01/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086865851 | CMS |
| Novo Nordisk Inc | $21.87 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096898810 | CMS |
| Novo Nordisk Inc | $24.96 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097541171 | CMS |
| Novo Nordisk Inc | $24.85 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096999773 | CMS |
| PFIZER INC. | $25.55 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131673860 | CMS |
| PFIZER INC. | $15.16 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130884584 | CMS |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $23.17 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153668700 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.